Related Experiment Video
Updated: Mar 7, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Gifts, Blind Spots, and Gray: Canadian Student Pharmacists' Perceptions of Pharmaceutical Industry Interactions
Grace Song1, Raveena Bhatti1, Jamie Falk2
1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Objective:
To evaluate Canadian student pharmacists' interactions with the pharmaceutical industry and their perceptions of potential bias, implications for future behavior as pharmacists, and conflicts of interest (COI).
Methods:
A national, cross-sectional survey was administered to students enrolled in accredited Canadian PharmD programs. The 31-item instrument examined acceptance of industry gifts, attendance at sponsored events, educational exposure to COI, and institutional policy awareness. Recruitment was conducted via email through student liaisons and associations.
Results:
Of 4878 eligible students, 563 initiated and 483 completed the survey (response rate: 9.9%). A majority (88%) reported accepting small gifts, and 39% accepted larger gifts (eg, conference funding). Most students (75%) had attended pharmaceutical-sponsored educational or social events. Despite high participation, only a minority (6-17%) viewed these interactions as problematic regarding the impact on their behavior as future pharmacists. About one-third had never considered the implications of accepting gifts or awards. Over half of respondents believed pharmaceutical representatives were valuable information sources, and nearly one-third planned to meet with them in practice. Instruction on COI was inconsistent; only 31% received annual education, and over half were unaware whether their faculty had a COI policy. Observed behaviors of faculty and leaders appeared to normalize industry relationships for many students.
Conclusion:
Canadian student pharmacists report frequent interactions with the pharmaceutical industry and limited awareness of associated impacts on future professional behavior. These findings highlight the need for more robust, curriculum-based education on COI and industry influence to promote critical reflection and professional integrity.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Biopharmaceutics and Pharmacokinetics: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics: Drug–Drug Interactions
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

